ProfileGDS4718 / 222428_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 91% 89% 94% 88% 90% 95% 97% 90% 88% 90% 93% 85% 93% 94% 94% 93% 93% 93% 95% 93% 88% 90% 91% 91% 90% 94% 89% 94% 91% 96% 93% 95% 86% 88% 97% 96% 93% 90% 89% 95% 92% 95% 94% 95% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.5250791
GSM549102patient 115, normal, homogenized [OPG study]8.9416589
GSM549104patient 119, normal, homogenized [OPG study]10.122494
GSM549108patient 138, normal, homogenized [OPG study]8.7509688
GSM549119patient 077, normal, homogenized [OPG study]9.2645290
GSM549133patient 032, cancer, homogenized [OPG study]10.177695
GSM549139patient 042, cancer, homogenized [OPG study]10.89597
GSM549099patient 107, normal, homogenized [OPG study]9.1538690
GSM549109patient 139, normal, homogenized [OPG study]8.939688
GSM549110patient 046, normal, homogenized [OPG study]9.2704290
GSM549114patient 063, normal, homogenized [OPG study]9.8507293
GSM549122patient 082, normal, homogenized [OPG study]8.4185885
GSM549134patient 033, cancer, homogenized [OPG study]9.7687693
GSM549136patient 036, cancer, homogenized [OPG study]9.9580394
GSM549140patient 044, cancer, homogenized [OPG study]9.9939394
GSM549111patient 047, normal, homogenized [OPG study]9.8096493
GSM549113patient 057, normal, homogenized [OPG study]9.8994893
GSM549132patient 031, cancer, homogenized [OPG study]9.7528993
GSM549137patient 038, cancer, homogenized [OPG study]10.057895
GSM549142patient 047, cancer, homogenized [OPG study]9.1770593
GSM549100patient 110, normal, homogenized [OPG study]8.8482188
GSM549107patient 135, normal, homogenized [OPG study]9.3444590
GSM549115patient 068, normal, homogenized [OPG study]9.5591
GSM549116patient 072, normal, homogenized [OPG study]9.5317191
GSM549120patient 078, normal, homogenized [OPG study]9.1970390
GSM549131patient 030, cancer, homogenized [OPG study]9.9343694
GSM549118patient 074, normal, homogenized [OPG study]9.1054389
GSM549129patient 027, cancer, homogenized [OPG study]9.6920194
GSM549123patient 088, normal, homogenized [OPG study]9.4799391
GSM549124patient 006, cancer, homogenized [OPG study]10.397796
GSM549126patient 015, cancer, homogenized [OPG study]9.5837793
GSM549128patient 025, cancer, homogenized [OPG study]10.299495
GSM549103patient 117, normal, homogenized [OPG study]8.4920786
GSM549117patient 073, normal, homogenized [OPG study]9.0830388
GSM549138patient 041, cancer, homogenized [OPG study]10.898997
GSM549141patient 045, cancer, homogenized [OPG study]10.659896
GSM549130patient 028, cancer, homogenized [OPG study]9.6638593
GSM549101patient 111, normal, homogenized [OPG study]9.0842990
GSM549105patient 128, normal, homogenized [OPG study]9.0090689
GSM549106patient 134, normal, homogenized [OPG study]10.327895
GSM549112patient 048, normal, homogenized [OPG study]9.7271592
GSM549125patient 011, cancer, homogenized [OPG study]10.118195
GSM549127patient 024, cancer, homogenized [OPG study]9.9022694
GSM549135patient 035, cancer, homogenized [OPG study]10.117795